CAPPELLINI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 1.957
NA - Nord America 1.811
AS - Asia 991
SA - Sud America 68
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 11
OC - Oceania 6
Totale 4.858
Nazione #
US - Stati Uniti d'America 1.789
IE - Irlanda 530
CN - Cina 362
SE - Svezia 357
SG - Singapore 301
DE - Germania 259
UA - Ucraina 238
RU - Federazione Russa 204
IT - Italia 164
TR - Turchia 158
HK - Hong Kong 84
FI - Finlandia 69
BR - Brasile 60
GB - Regno Unito 60
VN - Vietnam 34
IN - India 24
BE - Belgio 20
EU - Europa 13
FR - Francia 13
PL - Polonia 13
CA - Canada 11
AT - Austria 8
MX - Messico 8
NL - Olanda 7
AU - Australia 5
IQ - Iraq 5
ZA - Sudafrica 5
JP - Giappone 4
BD - Bangladesh 3
EC - Ecuador 3
ES - Italia 3
KZ - Kazakistan 3
MA - Marocco 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KE - Kenya 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
AR - Argentina 1
CO - Colombia 1
CR - Costa Rica 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MM - Myanmar 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.858
Città #
Dublin 530
Chandler 366
Jacksonville 181
Singapore 156
Izmir 150
The Dalles 95
Rome 93
Boardman 89
Hong Kong 84
Ann Arbor 79
Wilmington 77
Dallas 73
Nanjing 73
Ashburn 72
Woodbridge 62
Beijing 51
Hefei 47
Lawrence 46
Princeton 46
Brooklyn 45
Moscow 38
New York 29
Ogden 29
Nanchang 28
Brandenburg 25
Bologna 23
Helsinki 23
Los Angeles 21
Brussels 20
Dearborn 19
Munich 17
Changsha 16
Dong Ket 16
Milan 15
Des Moines 14
Inglewood 14
San Francisco 14
Jiaxing 13
Orange 13
Santa Clara 13
Hebei 12
Kunming 12
Tianjin 12
Falls Church 11
Warsaw 11
Seattle 10
Shenyang 9
São Paulo 9
Cassino 8
Ho Chi Minh City 8
Verona 8
Lanzhou 7
Orem 7
Salerno 7
Boston 6
Fairfield 6
Hangzhou 6
Hanoi 6
Pune 6
Chennai 5
Haikou 5
Manchester 5
Montreal 5
Nuremberg 5
Vienna 5
Amsterdam 4
London 4
Ningbo 4
Tokyo 4
Toronto 4
Turku 4
Ankara 3
Atlanta 3
Baghdad 3
Changchun 3
Chicago 3
Hanover 3
Norwalk 3
Tappahannock 3
Zhengzhou 3
Almaty 2
Auburn Hills 2
Bengaluru 2
Cambridge 2
Canberra 2
Clifton 2
Denver 2
Frankfurt am Main 2
Houston 2
Jinan 2
Johannesburg 2
Katowice 2
Kocaeli 2
Luxembourg 2
Melbourne 2
Mumbai 2
Nairobi 2
Olomouc 2
Porto Alegre 2
Raleigh 2
Totale 3.097
Nome #
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 180
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 167
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. 151
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers. 138
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. 135
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 129
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment 118
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 118
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 118
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 117
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 114
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 112
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. 111
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 111
Metabolism and signaling activities of nuclear lipids. 111
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 111
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. 111
Flow cytometric detection of total and serine 473 phosphorylated Akt. 110
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 109
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. 109
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 108
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 108
Molecular characterization of protein kinase C-alpha binding to lamin A. 107
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 106
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 105
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 104
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 104
Targeting the liver kinaseB1/AMP-activated protein kinasepathway as a therapeutic strategyfor hematological malignancies 103
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 103
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. 103
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 102
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 101
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 100
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 100
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. 100
The controversial nuclear matrix: a balanced point of view. 99
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 98
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 97
Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. 96
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. 95
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. 94
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 93
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. 86
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 73
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 70
Therapeutic targeting of CK2 in acute and chronic leukemias 67
Totale 5.002
Categoria #
all - tutte 24.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 54 5 47 1 53 9 68
2021/2022345 7 4 1 26 35 9 7 34 10 17 69 126
2022/20231.568 103 145 57 154 87 261 0 93 622 5 17 24
2023/2024207 24 16 19 3 6 13 26 16 58 4 2 20
2024/2025662 24 12 44 9 54 10 72 59 235 6 68 69
2025/2026643 77 222 58 49 130 107 0 0 0 0 0 0
Totale 5.002